PATENT CLAIM ANALYSIS

Application Number: 15892280
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["435", "007220"]

Abstract:
Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.

Claim (Index 30):
The method of  claim 25 , further comprising administering to the subject an adjuvant.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.08696
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14806047', '14106477', '13133817', '09672126', '14341317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6137651367663286
- 35 USC 102 Novelty (BERT): 0.5614188875433531
- Combined Prediction Score: 0.6085305118440311
- Mean Citation Score: 322.01186400000006
- Max Citation Score: 572.4656
- Similarity Product: 315.5048409711838

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test